PCYC

Pharmacyclics, Inc. News Headlines

$138.65
*  
1.64
1.17%
Get PCYC Alerts
*Delayed - data as of Nov. 25, 2014  -  Find a broker to begin trading PCYC now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
View:    PCYC After Hours
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By
Stocks Under Pressure Amid Global Economic Concerns - U.S. Commentary
10/7/2014 10:25:00 AM - RTT News


Individual Investor Portfolio: Major Sectors Are Beginning To Move In Opposing Directions
10/4/2014 3:39:00 AM - Seeking Alpha


Gilead Sciences, Inc. Stock's Stunning New Opportunity
9/30/2014 8:15:02 AM - Motley Fool


FDA Decision On Imbruvica Will Push Pharmacyclics Higher
9/29/2014 1:32:00 PM - Seeking Alpha


Cramer's Lightning Round - People Need H&R Block More Than Ever (9/17/14)
9/18/2014 4:53:00 AM - Seeking Alpha


Modest Weakness Remains Visible On Wall Street - U.S. Commentary
9/11/2014 12:04:00 PM - RTT News


Stocks Remain Nearly Flat In Mid-Day Trading - U.S. Commentary
9/10/2014 12:16:00 PM - RTT News


Infinity Pharma (INFI) Shares Skyrocket on Cancer Drug Partnership - Stocks in the News
9/3/2014 5:47:20 PM - Zacks.com


Gilead: Rising Short Interest Provides Yet Another Reason To Own The Stock
8/15/2014 2:40:00 PM - Seeking Alpha


Bull of the Day: Gilead Sciences (GILD) - Bull of the Day
8/13/2014 2:06:00 AM - Zacks.com


Bull of the Day: Gilead Sciences (GILD) - Bull of the Day
8/12/2014 2:06:00 PM - Investopedia


Patient Bulls Finally Get A New Entry Point, Thanks To Inflation Fears
8/4/2014 4:45:00 PM - Seeking Alpha


Pharmacyclics Incurs Q2 Loss, Revenues Up on Imbruvica Sales - Analyst Blog
8/1/2014 4:10:00 PM - Zacks.com


Pharmacyclics (PCYC) Jumps: Stock Rises 15% - Tale of the Tape
7/30/2014 8:39:00 AM - Zacks.com


Stock Pickers Rule - Investment Ideas
7/30/2014 2:51:00 AM - Zacks.com


PCYC Makes Bullish Cross Above Critical Moving Average
7/29/2014 10:49:49 AM - BNK Invest


Pharmacyclics/Johnson & Johnson Drug Backed for EU Approval - Analyst Blog
7/28/2014 4:15:00 PM - Zacks.com


Medivation Significantly Undervalued, With Xtandi Weeks Away From Prostate Cancer Label Expansion
7/21/2014 2:06:00 PM - Seeking Alpha


Biotechs Have Their 'Irrational Exuberance' Moment: Time To Buy More?
7/21/2014 10:40:00 AM - Seeking Alpha


Halozyme Attracting Attention With Upcoming Adcom And Potential Blockbuster Pancreatic Cancer Treatment
7/8/2014 8:01:00 AM - Seeking Alpha


Individual Investor Portfolio Update: Diversifying For Growth
7/1/2014 1:40:00 AM - Seeking Alpha


Cramer's Mad Money - 9 Things To Watch In The Week Ahead (6/20/14)
6/22/2014 5:10:00 AM - Seeking Alpha


Fire Up The Immuno-Oncology Powerhouses: John McCamant
6/19/2014 5:39:00 PM - Seeking Alpha


Pharmacyclics' Imbruvica Under FDA Priority Review - Analyst Blog
6/10/2014 5:45:00 PM - Zacks.com


Encouraging Data on Pharmacyclics/J&J Drug - Analyst Blog
6/2/2014 11:10:00 AM - Zacks.com